Abstract 47 N-Methyl-D-Aspartate (NMDA) receptors are heteromultimeric ion channels that contain an 48 essential GluN1 subunit and two or more GluN2 (GluN2A-GluN2D) subunits. The 49 biophysical properties and physiological roles of synaptic NMDA receptors are dependent on 50 their subunit composition. In the basolateral amygdala (BLA), it has been suggested that the 51 plasticity that underlies fear learning requires activation of heterodimeric receptors composed 52 of GluN1/GluN2B subunits. In this study we investigated the subunit composition of NMDA 53 receptors present at synapses on principal neurons in the BLA. Purification of the synaptic 54 fraction showed that both GluN2A and GluN2B subunits are present at synapses and, co-55 immunoprecipitation revealed the presence of receptors containing both GluN2A and 56
Introduction
thought to be present, perhaps with each having distinct functional roles (Yashiro and Philpot 113 2008) . 114
The amygdala plays a central role in fear conditioning, with both fear learning and 115 extinction thought to result from NMDA receptor-dependent synaptic plasticity (LeDoux 116 Kohr 2011). In this study we investigated the subunit composition of synaptic NMDA 123 receptors at glutamatergic synapses on principal neurons in the basolateral amygdala. Our 124 results indicate that at these synapses, NMDA receptors are likely to be 125
GluN1/GluN2A/GluN2B heterotrimers. Receptors composed of GluN1/GluN2B 126 heterodimers do not appear to be present at these synapses. 127 128
Methods

129
All experiments were done using tissue isolated from the brains of Wistar rats. All 130 procedures were approved by the University of Queensland Animal Ethics Committee. 131
Lysates, PSD fraction purification, western blots and quantification 132
Tissues from the BLA and hippocampus were micro-dissected from 500 µm coronal brain 133 slices of adult Wistar rats (postnatal day 25-40). The tissues were homogenized with a 134
Teflon-glass potter in Tris buffer (30mM Tris, 1mM EGTA, 4mM EDTA, pH 7.4). All 135 buffers were supplemented with protease inhibitors (Roche). The homogenates were 136 centrifuged at 800 g for 10 min and the supernatants then centrifuged at 100,000 g for 1h at 137 4°C. The pellets were re-suspended in Tris buffer containing 0.5% Triton-X 100, incubated 138 on ice for 20min and layered over a 1M sucrose gradient. After 1 h centrifugation at 100,000 139 g, the resulting pellet was denoted as the Triton-insoluble postsynaptic density (PSD) fraction. 140
For total lysates, micro-dissected material was placed in ice-cold phosphate buffered saline 141 containing protease inhibitors and was homogenized using an 18 gauge needle before the 142 addition of sample buffer containing no bromophenol blue. Protein concentrations were then 143 determined using the Pierce BCA kit. PSD fractions were lysed in SDS sample buffer and 144 bromophenol blue was added to the lysates. All samples were denatured with DTT and boiled 145 for 5-10 min. They were then fractionated on 4-12% Bis-Tris gradient gels (Invitrogen) and 146 transferred to polyvinylidene difluoride membrane (Immobilon-P, Millipore) at 150V in 147 1XMOPS running buffer (Invitrogen). Blots were blocked in TBS containing 5% skim milk 148 powder, and probed with primary antibody, followed by incubation with horseradish 149 peroxidase-conjugated goat anti-rabbit or mouse IgG (Biorad) and detection by SuperSignal 150
West Pico or FEMTO chemiluminescent substrate (Pierce). Densitometry analysis was 151 carried out using NIH ImageJ software. 152
Immunoprecipitation 153 PSD fractions (250 μg) from the BLA and the hippocampus were solubilized in 2% SDS 154 buffer, then diluted in five volumes of 2% Triton buffer and centrifuged at 100,000 g for 30 155 min at 4°C. The resulting supernatants were classified as the PSD soluble fraction. 156
Supernatants were pre-cleared for 30 min at 4°C with 20 μl of 50% Protein A sepharose beads 157 (Amersham) slurry and 5 μg rabbit IgG (Sigma, 1mg/ml) then centrifuged for 5 min at 800g. 158
For immunoprecipitation, 3 μg of NMDA2A or NMDA2B antibody (both rabbit polyclonal 159 from Chemicon) was incubated with 20 μl 50% Protein A sepharose bead slurry for 30 min at 160 4°C and then added to the precleared supernatant overnight at 4°C with rotation. Samples 161
were then spun at 900g for 5 min at 4°C and the pellets recovered. Pellets were washed 3 162 times in SDS-Triton buffer before elution with sample buffer containing DTT and denatured 163 for 8 min at 70°C. Samples were run together with the PSD fraction input and the supernatant 164 resulting from the immunoprecipitation, transferred as described previously (Faber et al. 165 2006) and stained for NMDA2A (Millipore, mouse monoclonal), NMDA2B (Watanabe, 166 rabbit polyclonal) and PSD95 (Chemicon, mouse monoclonal). 167
Production of shRNA constructs 168
A series of 5 siRNA expression cassettes (SECs) were produced using the Ambion Silencer 169
Express siRNA expression cassette kit to knock down rat GluN2A gene expression. These 170 SECs, containing the mouse U6 RNA polymerase III promoter, a hairpin siRNA template and 171 an RNA polymerase III transcription termination site, were ligated into pBluescript 172 (Stratagene) digested with EcoR1 and HindIII. The sequences for these SECs were as follows 173 (GenBank-Rat NR2A NM_012573.3: 1-gacaacagtggacaacagc (786-804); 2-174 ggacttgtccttcactgag (1260-1278); 3-gtggtctatcaacgagcag (1720-1738 ); 4-gttctcccagggataagat 175 (3554-3572); 5-acactcattgccatcacag(4386-4404)). A scrambled control SEC (SCR) 176 (Ambion) was also used as a negative control. The SEC sequences were tested in HEK293T 177 cells co-transfected with rat GluN2A and GluN2B subunits. Sequence #2 showed the best 178 knock down and was therefore used for further experiments. To distinguish transfected 179 versus non-transfected cells in organotypic cultures, an EGFP PCR fragment from 180 pEF/myc/cyto/GFP (Invitrogen) with the promoter and terminator sequences, was ligated into 181 the SmaI site of the pBluescript SEC construct. A rat GluN2B knockdown construct was also 182 produced in the same way using an already published siRNA sequence (agctcgttcccaaaagagc) 183 (Tan et al. 2005) . 184
HEK293T expression of shRNA constructs 185 HEK293T cells were plated at a density of 1.5X10 5 cells per 35 mm well and were 186 transfected 24h later using FUGENE (Roche) as per the manufacturer's instructions with 187 constructs expressing rat GluN2 subunits (GluN2A and GluN2B), and the shRNA EGFP 188 constructs in a ratio of 1:1:1. Forty-eight hours later, the cells were checked for EGFP 189 expression (greater than 80% transfection efficiency was typically achieved), washed with 190 PBS and lyzed in 300 µl 1X sample buffer. 30 µl of this suspension was run on an SDS-191 PAGE gel, transferred and western blots carried out as described above. For 192 electrophysiological recordings, cells were transfected with constructs expressing rat GluN2 193 subunits (GluN2A or GluN2B), GluN1-1a subunits and the shRNA EGFP constructs in a ratio 194 of 1:1:1, then plated on cover slips that had been previously coated with polyornithine. 195
Cultures were maintained in d-APV (100 µM, Sigma) to decrease excitotoxic cell death but 196 this d-APV was washed out prior to electrophysiological recordings. 197
Organotypic cultures and biolistic transfection 198
Amygdala organotypic cultures were prepared according to the standard interface method 199 (Stoppini et al. 1991) . Coronal brain slices containing the BLA were prepared from P9 rats. 200
Rats were anesthetized using isoflurane, decapitated, and their brains removed into an ice-201 cold artificial cerebral spinal fluid (ACSF) solution containing (in mM) 118 NaCl, 25 202 NaHCO 3 , 10 glucose, 2.5 CaCl 2 , 1.2 NaH 2 PO 4 and 1.3 MgCl 2 . Brains were sliced into 300 203 µm thick coronal sections using a Leica VT1000S vibratome at 0°C, then transferred to 204 porous membrane inserts (Millicell inserts, Millipore) using a culture medium containing 205 50% OptiMEM (Invitrogen), 25% heat-inactivated horse serum and 25% Hanks balanced salt 206 Solution (Sigma) supplemented with D-glucose (6.5 g/l) and penicillin/streptomycin 207 (Invitrogen). The cultures were maintained at 37°C in a 5% CO 2 atmosphere for 2-3 days. 208
Gold particles (9mg, 1.6µm, Biorad) were mixed with 100 μl 0.05 M spermidine and 25 μg 209 purified plasmid DNA. DNA was precipitated by addition of 100 μl 5% CaCl 2 and the bullets 210 were washed in 100% ethanol and resuspended in 3 ml of 100% ethanol containing 211 0.05mg/ml polyvinylpyrrolidine. The mix was taken up in Tefzel tubing and the ethanol was 212 quickly removed before commencing rotation of the tube loading station (Biorad). The 213 particles were allowed to dry using a flow of nitrogen and the bullets were then cut to size. 214
Slices were shot using a Helios Gene Gun (Biorad) with a modified barrel (O'Brien et al,  215 2001) approximately 3 cm from the slice through a 70 μm nylon mesh (Falcon) at a pressure 216 of 70-80psi approximately 2 h after plating. 217
Viral vectors 218
The knock-down hairpin constructs were produced using annealed and kinased 219 oligonucleotides that had been ligated into the pll3.7 vector (courtesy of Luk Van Parijs) 220 digested with Hpa and Xho. All plasmids (pMDG, pMDL g/p RRE, pRSV Rev, and the 221 pll3.7 transfer vector) were prepared using the Qiagen Endofree maxiprep kit and lentivirus 222 was prepared via calcium phosphate transfection of a 60 -80 % confluent T175 flask of 223 HEK293T cells. Cells were grown in DMEM (Invitrogen) plus 10% foetal bovine serum 224 (FBS) and penicillin/streptomycin (Invitrogen). 13.2 µg of transfer vector together with 6.6 225 µg of the other 3 plasmids were transfected per T175 flask. Plasmids were diluted to 0.5 μg 226 ml -1 in TE buffer and made up to a volume of 900 μl with sterile distilled water. 100ul of 227 2.5M CaCl 2 was added together with 1ml of 2XBBS(50 mM BES, 280 mM NaCl, 1.5 mM 228 Na2HPO4, pH= 6.95). This was incubated for 15 min at room temperature before adding the 229 mix drop-wise to the cells. The cells were incubated for 3-4 h at 37 0 C in 5% CO 2 before the 230 addition of new medium containing 10 mM sodium butyrate (Sigma). Viral supernatents were 231 taken at 24 and 48 h post transfection and ultracentrifuged at 50,000 g for 90 min. The virus 232 was re-suspended overnight at 4 0 C and then re-suspended in 300 μl PBS. Viral titers were 233 determined by the addition of varying amounts of concentrated virus on known numbers of 234 HEK293T cells. Titers of 10^8 -10^9 IU / ml were routinely produced. 235 Animals (4-5 weeks of age) were anesthetized with a ketamine (100mg/kg) /xylazine 236 (20 mg/kg) mixture. After animals were placed in a stereotaxic frame an incision was made 237 to expose the skull surface. A small hole was drilled in the skull and the underlying dura 238 removed. A broken micropipette filled with Lentivirus was lowered into the BLA and 1 µl of 239 virus was delivered. The pipette was left in place for 5 min to minimize diffusion of the virus 240 back along the injection tract, after which it was removed, the hole sealed with bone wax, and 241 the incision closed with surgical staples. Animals were scarified after 7 -10 days recovery 242 and brain slices prepared as described above. 243
Primary rat cortical neuron cultures 244
Primary cultures of rat cortical neurons were prepared from freshly isolated embryonic (E18) 245 cortex from Wistar rats. The isolated cortices were disrupted with a blade then transferred to a 246 15ml falcon tube and gently dispersed in dissection medium (1x HBSS, penicillin, 247 streptomycin, pyruvate, Hepes 10mM, Glucose 30 mM). The supernatant was then taken off 248 and the pellet resuspended with papain (17u/ml, Worthinghton, suspension 31.3 u/mgP) made 249 up in dissection medium and supplemented with 1% DNase (Sigma) for 20 min at 37°C then 250 the sedimented material was washed 3 times in plating medium (Neurobasal medium 251 supplemented with 5% heat-inactivated bovine fetal serum, pen strep, GlutamaxI and 2% 252 B27). After the last wash, the resulting pellet was resuspended and triturated in 2ml of 253 plating medium using a fire-polished glass Pasteur pipette (up and down passes). The axon, soma, single apical dendrite and 5 basal dendrites. The axon was 300 μm in length and 308 0.7 μm in diameter. The soma was spherical with a 15 μm diameter. The diameter of the 309 apical dendrite prior to the first branch point (75 μm) was 1.5 μm. and this dendrite split into 310 secondary, tertiary, and quaternary branches each 60 μm in length and 0.5 μm in diameter. 311
As the diameter of basal-like dendrites was found to be constant throughout the dendritic tree, 312
we simplified the structure of each dendrite using the 3/2 power rule, collapsing the branches 313 into a single equivalent cylinder (length 700 μm, width 2 μm). 314
The resting membrane potential was set to 0 mV. Passive electrical parameters were: 315
Rm 165,000 Ω cm -2 , Cm 1 μF cm -2 in the somatic compartment. In the dendrites, Rm was 316 reduced to 110,000 Ω cm -2 , and capacitance was doubled to account for the dendritic spines. 317
The axial resistivity Ri was 150 Ωcm except in the axon where it was 50Ω cm. A single 318 electrode voltage-clamp point process (SEClamp; Rs 13 MΩ) was placed on the soma. These 319 settings yielded an input resistance that closely matched the experimental data (400 MΩ). 320
Synaptic inputs were distributed throughout the apical dendrite by placing a single NMDA 321 conductance on the midsection of each apical dendrite branch. The NMDA conductance was 322 modeled as having a reversal potential of 0 mV, an exponential rise, and a dual exponential 323 decay. The decay was implemented using the following formula: gmax*(1-(frac* e -t/tau1 + (1-324 frac)* e -t/tau2 ), where gmax is the maximum conductance, tau1 is the fast decay time constant, 325 tau2 is the slow decay time constant and frac is the relative contribution of the tau1 to the 326 peak current amplitude. Tau1, tau2 and frac were 16.5 ms, 123.5 ms, and 0.90 for GluN2A 327 synapses, and 35.5 ms, 269 ms, and 0.42 for GluN2B-containing synapses. These 328 deactivation time constants correspond to values measured in recombinant expression systems 329 and two NR2 (GluN2A-NR2D) or GluN3 (GluN3A, GluN3B) subunits. GluN2C expression 340 is confined to the cerebellum, whereas GluN2D is largely present early in development (Cull- subunits was low in P2 hippocampus (Fig. 1A) . Isolation of the synaptic fraction (see 356
Methods) showed that, together with PSD95, both GluN2A and GluN2B subunits were 357 clearly detectable (Fig. 1B) , showing that both subunits were present in the postsynaptic 358 density. Overall, expression of both subunits was similar in synaptic fractions from the 359 hippocampus and BLA (Fig. 1C) . Immunoprecipitation of NMDA receptors using GluN1 360 antibodies revealed that both GluN2A and GluN2B subunits were present in functional 361 receptors (Fig. 1D ). In the adult brain, heterotrimeric receptors containing 362 GluN1/GluN2A/GluN2B subunits are also present (Al-Hallaq et al. 2007 ; Sheng et al. 1994) . 363
Indeed, in some regions, it has been suggested that trimeric receptors may be the dominant 364 receptor present at mature synapses (Dunah and Standaert 2003; Luo et al. 1997 ). We 365 therefore tested whether the GluN2A and GluN2B subunits formed heterotrimeric assemblies 366 in the BLA (Sans et al. 2000; Sheng et al. 1994 ). Synaptic membrane fractions from adult 367 hippocampus were immunoprecipitated using either GluN2A or anti-GluN2B antibodies. 368
Probing the immunoprecipitated GluN2A protein with anti-GluN2B clearly revealed the 369 presence of di-GluN2A/GluN2B complexes in the hippocampus and BLA (Fig. 1D) . 370
Similarly, immunoprecipitated GluN2B protein showed the presence of GluN2A subunits 371 (Fig 1D) . Together, these results show that as in the hippocampus tri-heteromers containing 372
GluN2A and GluN2B subunits are present at excitatory synapses in the BLA. 373
374
RNAi knockdown of NMDA receptor subunit expression 375
As currently available antagonists do not distinguish between heterodimers and 376 heterotrimers, we used short hairpin RNAi constructs to reduce the expression of individual 377 subunits in projection neurons, allowing us to investigate the role of these subunits in synaptic 378 transmission. Short hairpin RNAi constructs targeting GluN2A and GluN2B subunits were 379 prepared (see Methods), and the efficacy and specificity of these constructs was first tested in 380 HEK293T cells. Cells transfected with GluN2A, GluN2B and RNAi vectors were compared 381 to those expressing scrambled sequences. As shown in Fig 2, RNAi vectors against GluN2A 382 and GluN2B subunits selectively reduced expression of the targeted subunit ( Fig. 2A, B ; p < 383 0.05, n = 3) with no effect on the non-targeted subunit. 384
To verify that the reduction in GluN2 subunits resulted in reduced functional 385 receptors, we tested these vectors using electrophysiological recordings of NMDA receptor-386 mediated currents. HEK293 cells were co-transfected with GluN1/GluN2 subunits and either 387 the scrambled RNAi (Scr-RNAi), GluN2A-RNAi or GluN2B-RNAi. NMDA (50 µM) was 388 co-applied with 1 µM glycine. Whole-cell current amplitudes were measured relative to total 389 cell capacitance, calculated from a 10 mV voltage step response (Fig. 2C) . Expression of 390
GluN2A-RNAi significantly reduced the NMDA current in GluN1/GluN2A-transfected cells 391 compared to Scr-RNAi-transfected control cells (5.3 ± 2.3 pA/pF control Vs 2.3 ± 1.9 pA/pF 392 in 2A-RNAi ; p < 0.05, n = 9 and 13 respectively, Fig. 2D ), whereas expression of GluN2B-393
RNAi had no significant effect (p > 0.05, n = 7, Fig. 2D) . Similarly, only the GluN2B-RNAi 394 construct reduced NMDA currents in GluN1/GluN2B-transfected HEK293T cells (p < 0.05, n 395 = 8, 11 and 9 respectively, Fig. 2D ). These results show that the RNAi constructs were 396 specific for their targeted subunit, and could efficiently reduce the expression of the subunit 397 protein and the number of membrane-bound functional receptors containing this subunit. To 398 confirm that these RNAi vectors could effectively reduce expression in neurons we used viral 399 transfection in cultured neurons (Methods). As in HEK293 cells, viral expression of RNAi 400 vectors against GluN2A or GluN2B in cultured effectively reduced expression of each 401 subunit (Fig 2) . Delivery of GluN2A-RNAi constructs by biolistic transfection of BLA neurons (Fig. 3A  422 upper traces) significantly slowed the NMDA receptor-EPSC decay (τ w :154 ± 10 ms, n = 9) 423 as compared to that of cells transfected with scrambled RNAi (τ w : 99 ± 11 ms, n =5, p < 424 0.05). In contrast, delivery of GluN2B-RNAi ( (Fig. 4A) . Ifenprodil also had no significant effect on AMPA receptor-448 mediated EPSCs that were fully blocked by the AMPA/kainate receptor antagonist NBQX 449 (Fig. 4A, right) showing that it is selectively acting at NMDA receptors (Delaney et al. 2012) . 450
In contrast, in neurons transfected with GluN2A-RNAi, NMDA receptor-mediated EPSCs 451 were blocked by ifenprodil (49 ± 7 %, p < 0.05, n = 6, Fig. 4B,C) application of ifenprodil at a concentration that clearly blocks synaptic GluN1/GluN2B 487 heterodimeric receptors (Delaney et al. 2012 ), has no effect on the NMDA-receptor mediated 488 EPSC. Moreover, reducing GluN2B expression in mature neurons was without effect on the 489 kinetics of NMDA receptor mediated EPSCs (Fig. 3) suggesting that these synapses do not 490 express GluN1/GluN2B heterodimers. One possible explanation for this discrepancy is that 491 the slow EPSC kinetics measured at the soma results from electrotonic filtering of currents 492 generated in the distal dendritic tree (Williams and Mitchell 2008) . To test this possibility we 493 constructed a computational model of BLA projection neurons (Fig. 5) . GluN1/GluN2A and 494 GluN1/GluN2B heterodimer conductances incorporated into the model were given 495 deactivation time constants derived from recombinant expression systems . 496
When synapses containing GluN1/GluN2A heterodimers were placed on the soma, the 497 resultant EPSC, at the soma, had a weighted decay time constant of 53 ms. Distributing these 498 receptors along the dendrite (> 60 µm from the soma) yielded a weighted decay time constant 499 of ~93 ms, strikingly similar to the experimentally measured time-constant (90 ± 8 ms in 500 organotypic slices; 102 ± 11 ms acute slices). The kinetics of the GluN1 / GluN2A / GluN2B 501 heterotrimers is not known; however, it is likely that the offset time constant of these 502 receptors is dominated by the properties of GluN2A containing receptors (Santucci and 503
Raghavachari 2008). 504
As expected, modelling shows that dendritic filtering also slowed the time-course of 505 GluN1 / GluN2B conductances (Fig. 5C) . The decay time constant of a somatically recorded 506 pure GluN1/GluN2B current was predicted to be 277 ms, whereas a synaptic conductance 507 comprising equal proportions of GluN1/GluN2A and GluN1/GluN2B heterodimers predicted 508 a current with a weighted decay time constant of 225 ms, considerably slower than the 509 experimentally recorded EPSC decay. Furthermore, our modelling shows that dendritic 510 filtering would not obscure the reduction of the synaptic current's decay time expected from 511 ifenprodil's selective attenuation of GluN1/GluN2B receptors (Fig. 5D) . If dihetromeric 512 GluN1/GluN2B receptors provided half of the synaptic conductance, an 80% reduction of the 513 GluN2B conductance by ifenprodil would enhance the decay of the synaptic current by 43% 514 (from 224.5 ms to 129.1 ms). These results support our molecular and pharmacological data, 515
indicating that in mature BLA projection neurons, synaptic NMDA receptors are unlikely to 516 contain GluN1/GluN2B heterodimers. 517 518
Functional role of synaptic GluN2B subunits 519
Our results show that at mature synapses in BLA projection neurons, the postsynaptic 520 density contains both GluN2A and GluN2B subunits. However, the kinetic and 521 pharmacological properties of the NMDA receptor-mediated EPSC indicate that 522 GluN1/GluN2B heterodimeric receptors make little or no contribution at these synapses. 523
Thus, the GluN2B subunits present in the PSD must assemble as a heterotrimeric 524 GluN2B subunits is essential for LTP. We therefore tested if a similar interaction may be 533 required in the BLA. As shown previously (Faber et al. 2005) , tetanic stimulation (1sec 30 534 Hz x 2) of these inputs robustly evoked LTP (161 ± 19%; n=5). However, when GluN2B 535 subunit expression was reduced using RNAi, it was not possible to evoke LTP (87 ± 37%; 536 n=6) (Fig. 6A) . In contrast, application of ifenprodil (5 µM) had no effect on LTP (160 ± 10 537 % ; n=4) (Fig 6B) . NMDA receptor-dependent LTP results from influx of calcium via 538 NMDA receptors, activation of CaMKII and activation of a signalling cascade that ultimately 539 results in LTP. This CaMKII is thought to be anchored at excitatory synapses by binding to 540 GluN2B subunits (Barria and Malinow 2005) . In agreement with this possibility, LTP at 541 BLA synapses was also blocked by incubation of slices in the CaMKII inhibitor KN-62 (88 ± 542 13 %; n=5; Fig. 6C) . 543 544 Discussion 545
We have examined the subunit composition of NMDA receptors present at 546 glutamatergic synapses on principal neurons in the BLA. Our results show that (1) both 547
GluN2A and GluN2B subunits are present at excitatory synapses on these neurons (2) NMDA 548 receptors present at mature synapses are most likely heterotrimeric proteins containing 549 GluN1/GluN2A/GluN2B subunits and, the kinetics and pharmacology of these receptors are 550 dominated by the properties of GluN2A (3) GluN2B subunits are required for activation of 551
CaMKII-dependent LTP induced by tetanic stimulation at these synapses and (4) 552 GluN1/GluN2B heterodimers are either not present at these synapses or make a minor 553 , and as also evident from our purification (Fig. 1) . 582
Previous studies have used pharmacological approaches to determine the subunit composition 583 of NMDA receptors. However, these studies have relied on antagonists tested in recombinant 584 systems that can discriminate receptors containing GluN2A from those containing GluN2B, 585 but do not allow separation of heterodimeric from heterotrimeric receptors. 586
Four lines of evidence indicate that NMDA receptors at mature synapses are likely to 587 be trimeric, containing GluN1/GulN2A/GluN2B subunits. Firstly, immunoprecipitation of 588 NMDA receptors using the synaptic fraction shows that the GluN2A and GluN2B subunits 589 are present as heterotrimers in the BLA. Secondly, neither NMDA receptor-mediated EPSCs, 590 nor LTP at these synapses was affected by ifenprodil at a concentration that maximally and 591 selectively blocks GluN1/GluN2B receptors, suggesting that such receptors are not present at 592 these synapses. Thirdly, when GluN2A expression is reduced using RNAi, the NMDA 593 receptor-mediated EPSC displays slower kinetics and becomes sensitive to ifenprodil, 594
showing that GluN1/GluN2B heterodimers can replace receptors in the postsynaptic density. 595
In contrast, when GluN2B subunits expression is reduced, there is no effect on the kinetics of 596 NMDA receptor-mediated EPSCs, whereas modelling indicates that such a change would be 597 
